The top 5 pathways are displayed in Figure 3H and Supplementary Table S6, indicating that they participate in proteoglycans in cancer, the estrogen signaling pathway, endocrine resistance, and the PI3K-Akt signaling pathway. This evidence concerns the gene AKT1 and cancer.